Beta Bionics Price Target Raised to $16.00/Share From $14.00 by Baird
Ratings actions from Benzinga: GMT) Beta Bionics Is Maintained at Neutral by BairdRatings actions from Benzinga
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.